Strides Shasun announces completion of USFDA inspection for its formulations facility

Last Updated : May 30 2017 | 12:01 AM IST

Receives Form 483 with three observations

Strides Shasun announced the completion of USFDA inspection of its formulations facility in Bangalore. The Company has been issued a Form 483 with 3 observations.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Strides Shasun intimates of successful USFDA inspection of Cuddalore manufacturing facility

Strides Shasun intimates of successful USFDA inspection of API facility at Puducherry

Strides Shasun's Cuddalore plant completes USFDA inspection

Strides Shasun's plant completes successful USFDA inspection

Strides Shasun R&D unit gets USFDA inspection closure report

First Published: May 29 2017 | 9:10 AM IST

Explore News

Market LIVE
Parliament Winter Session 2024 LIVE
Latest News LIVE
Market Today
Stocks To Watch Today
Mobikwik IPO listing
IGI IPO Allotment
IND vs AUS 3rd Test Day 5 LIVE
IPO News
Business Standard at 50